Katarina Luptakova - CHIEF MEDICAL OFFICER at Xilio Therapeutics, Inc.

Issuer-level insider activity

Role
Chief Medical Officer
Issuer ticker
XLO on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Katarina Luptakova since 06 Oct 2025

Reported holdings for Katarina Luptakova in Xilio Therapeutics, Inc.

Form 4 holding CHIEF MEDICAL OFFICER

Xilio Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
33,250
Estimated value
$49,062
Report date
01 Jan 2026
Price
$0.9837
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF MEDICAL OFFICER

Xilio Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
451,885
Estimated value
Report date
31 Dec 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Katarina Luptakova in Xilio Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .